Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
CAS No. 184882-07-3
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside( ——— )
Catalog No. M39745 CAS No. 184882-07-3
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionPelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
-
DescriptionPelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number184882-07-3
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pomalidomide-PEG3-OH
Pomalidomide-PEG3-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
-
Theasaponin E2
Theasaponin E2 has antitumor activity.
-
ARN25068
ARN25068 is a potent inhibitor of GSK-3β, FYN, and DYRK1A protein kinases, exerting its activity in the sub-micromolar range. This compound effectively addresses tau hyperphosphorylation .
